Correlation of vibratory quantitative sensory testing and nerve conduction studies in patients with diabetes

被引:31
作者
Kincaid, John C.
Price, Karen L.
Jimenez, Maria C.
Skljarevski, Vladimir
机构
[1] Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Indianapolis, IN 46285 USA
[2] Indiana Univ, Dept Neurol, Indianapolis, IN 46204 USA
关键词
correlation; diabetes; nerve conduction studies; quantitative sensory testing; vibration;
D O I
10.1002/mus.20880
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Monitoring the course of diabetic peripheral neuropathy (DPN) remains a challenge. Besides clinical examination, nerve conduction studies (NCS) and quantitative sensory testing (QST) are the most commonly used methods for evaluating peripheral nerve function in clinical trials and population studies. In this study the correlation between vibratory QST and NCS was determined. Patients (N = 227) with diabetes mellitus participated in this multicenter, single-visit, cross-sectional study. QST of vibration measured with the CASE IV system was compared with a composite score of peroneal motor and tibial motor NCS and with individual attributes of peroneal, tibial, and sural nerves. The correlation between QST and composite score of NCS was 0.234 (Pearson correlation coefficient, P = 0.001). The correlations between QST and individual attributes of NCS ranged from 0.189 to 0.480 (Pearson correlation coefficients, P < 0.001). The low to moderate correlation between QST and NCS suggests that these tests cannot replace each other but are complementary.
引用
收藏
页码:821 / 827
页数:7
相关论文
共 30 条
[2]  
[Anonymous], 2002, NURS ETHICS, V9, P105
[3]   Development and validity testing of the neuropathy total symptom score-6: Questionnaire for the study of sensory symptoms of diabetic peripheral neuropathy [J].
Bastyr, EJ ;
Price, KL ;
Bril, V .
CLINICAL THERAPEUTICS, 2005, 27 (08) :1278-1294
[4]   Value of repeated measures of nerve conduction and quantitative sensory testing in a diabetic neuropathy trial [J].
Bird, Shawn J. ;
Brown, Mark J. ;
Spino, Cathie ;
Watling, Sharon ;
Foyt, Howard L. .
MUSCLE & NERVE, 2006, 34 (02) :214-224
[5]   Diabetic neuropathies - A statement by the American Diabetes Association [J].
Boulton, AJM ;
Vinik, AI ;
Arezzo, JC ;
Bril, V ;
Feldman, EL ;
Freeman, R ;
Malik, RA ;
Maser, RE ;
Sosenko, JM ;
Ziegler, D .
DIABETES CARE, 2005, 28 (04) :956-962
[6]   Comparison of a neurothesiometer and vibratron in measuring vibration perception thresholds and relationship to nerve conduction studies [J].
Bril, V ;
Kojic, J ;
Ngo, M ;
Clark, K .
DIABETES CARE, 1997, 20 (09) :1360-1362
[7]   Comparison of vibration perception thresholds obtained with the Neurothesiometer and the CASE IV and relationship to nerve conduction studies [J].
Bril, V ;
Perkins, BA .
DIABETIC MEDICINE, 2002, 19 (08) :661-666
[8]   NIS-LL: The primary measurement scale for clinical trial endpoints in diabetic peripheral neuropathy [J].
Bril, V .
EUROPEAN NEUROLOGY, 1999, 41 :8-13
[9]   Longitudinal assessment of diabetic polyneuropathy using a composite score in the Rochester diabetic neuropathy study cohort [J].
Dyck, PJ ;
Davies, JL ;
Litchy, WJ ;
OBrien, PC .
NEUROLOGY, 1997, 49 (01) :229-239
[10]   VARIABLES INFLUENCING NEUROPATHIC END-POINTS - THE ROCHESTER DIABETIC NEUROPATHY STUDY OF HEALTHY-SUBJECTS [J].
DYCK, PJ ;
LITCHY, WJ ;
LEHMAN, KA ;
HOKANSON, JL ;
LOW, PA ;
OBRIEN, PC .
NEUROLOGY, 1995, 45 (06) :1115-1121